Elevet+ Oestradiol Benzoate Injection

Država: Australija

Jezik: engleski

Izvor: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktivni sastojci:

OESTRADIOL BENZOATE

Dostupno od:

AVET HEALTH LIMITED

Farmaceutski oblik:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Sastav:

OESTRADIOL BENZOATE STEROID-ESTROGEN Active 1.0 mg/ml

Jedinice u paketu:

100 mL; 50 mL

Razred:

VM - Veterinary Medicine

Područje terapije:

ENDOCRINE SYSTEM

Proizvod sažetak:

Poison schedule: 4; Withholding period: MEAT: Zero (0) days. MILK: Zero (0) day s. EXPORT SLAUGHTER INTERVAL (ESI): Zer o (0) days. Before using this product, c onfirm the current ESI from AVet Health Pty Ltd on 1300 28 38 28 or the APVMA we bsite (www.apvma.gov.au/residues).; Host/pest details: CATTLE: [ANOESTRUS, INDUCTION OF OVULATION, SYNCHRONISATION OF OESTRUS & OVULATION]

Status autorizacije:

Registered

Datum autorizacije:

2023-07-01

Uputa o lijeku

Elevet+ Oestradiol Benzoate Injection
92658/136246
Product Name:
APVMA Approval No:
Label Name:
Elevet+ Oestradiol Benzoate Injection
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
1 mg/mL OESTRADIOL BENZOATE
Claims:
To improve the precision of the onset of oestrus and maximise
fertility in oestrus
synchronisation programmes using an intravaginal insert containing
progesterone in cycling
cattle.
To induce oestrus and ovulation after progesterone priming with an
intravaginal insert
containing progesterone in the treatment of anoestrus in cattle.
Net Contents:
50 mL
100 mL
Directions for Use:
Restraints:
Contraindications:
Contraindicated for administration in high doses to pregnant cattle as
this has been shown
to cause abortion.
Precautions:
Side Effects:
Dosage and
Administration:
Use the contents within 24 hours of first broaching of the vial.
Discard the unused portion. RLP APPROVED
Administer via intramuscular injection.
For use in oestrus synchronisation programmes and treatment of
anoestrus in cattle: Inject
2 mL at the time of administration of the intravaginal insert
containing progesterone.
Inject a further 1 mL between 24 and 48 hours after the removal of the
intravaginal insert
containing progesterone.
General Directions:
MODE OF ACTION:
The intramuscular injection of oestradiol benzoate at the initiation
of progesterone
treatment in cycling cattle (e.g. at the same time as the
administration of an intravaginal
insert containing progesterone) results in follicular turnover and the
emergence of a new
follicular wave about four days after treatment. The synchronous
emergence of this new
follicular wave both enhances the precision of the onset of oestrus
and ensures a high
fertility oocyte at ovulation after the cessation of progesterone
treatment.
The intramuscular injection of oestradiol benzoate during the
pro-oestrus period, induced
by progesterone priming (e.g. following removal of the intravaginal
insert containing
progeste